Last update:

Medications news

Medications

FDA approves Waskyra for Wiskott-Aldrich syndrome

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).

Medications

Little awareness of medical and psychological complexities of steroid cream withdrawal

There is little awareness, particularly among clinicians, of the medical and psychological complexities of "topical steroid withdrawal"—the body's adverse response to the prolonged use of these powerful creams to treat ...

Medications

How statins cause muscle aches

Many people stop taking cholesterol-lowering statins because they experience muscle aches, weakness, and fatigue.

Medications

Cannabis derivatives could provide new ovarian cancer treatments

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the effects of two chemical compounds sourced from cannabis on ovarian cancer cells have found that both show ...

Medications

Examining hidden risks of cannabis use among older adults

Cannabis use is rising among older adults, fueled by expanded legalization and people increasingly turning to cannabinoid-containing products to manage pain, sleep problems and other chronic issues.

Medications

ADHD prescriptions on the rise in Ontario, study finds

Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 to 2023, according to a new study from researchers at ICES, North York General, and The Hospital ...

Medications

EU to reward antibiotic innovation with new pharma rules

Drugmakers that develop new antibiotics are set to benefit from longer market protection in Europe after the EU agreed Thursday to a wide-ranging reform of pharmaceutical rules seeking to boost innovation and tackle antimicrobial ...

Medications

Opioids: Clarifying the concept of safe supply to save lives

In Canada, thousands of people use contaminated street opioids. To reduce overdoses, the country has been experimenting for the past 10 years with the distribution of pharmaceutical opioids as an alternative to illicit drugs. ...

Medications

Online tool detects drug exposure directly from patient samples

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete. People may forget what they took, use over‑the‑counter ...

Medications

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized in mRNA technology with the goal of advancing cancer treatments.

Medications

Researchers challenge FDA warning on common epilepsy drug

Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults with epilepsy, contrary to a safety warning by the Food and Drug Administration (FDA). The study has ...

Medications

Why acetaminophen works: New discovery ends longstanding mystery

A study from the Hebrew University of Jerusalem, published this week in Proceedings of the National Academy of Sciences reveals a previously unknown peripheral mechanism by which paracetamol (also known as acetaminophen, ...

Medications

Deliberately infected participants lead to penicillin advance

A unique study purposely giving participants Streptococcus pyogenes (Strep A) to learn how much penicillin it takes to prevent infection has found the amount needed is much lower than previously thought—a discovery that ...

Medications

Urinary tract infection drug recalled

Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination.

Medications

Diabetes drug shows benefits for patients with liver disease

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published ...